|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0087111,
umls-concept:C0178602,
umls-concept:C0205088,
umls-concept:C0205187,
umls-concept:C0205390,
umls-concept:C0441889,
umls-concept:C0450363,
umls-concept:C0600521,
umls-concept:C0684224,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-1-31
|
|
pubmed:abstractText |
PURPOSE AND OBJECTIVE: Three-dimensional conformal radiotherapy (3D-CRT) is a mode of high-precision radiotherapy designed to increase the tumor dose and decrease the dose to normal tissues. This study reports the final results of the first two dose levels (70.2 Gy and 75.6 Gy) of a phase I dose-escalation study using 3D-CRT for the treatment of non-small cell lung cancer.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-9117
|
|
pubmed:author |
pubmed-author:ArmstrongJJ,
pubmed-author:BurmanCC,
pubmed-author:FuksZZ,
pubmed-author:GinsbergRR,
pubmed-author:HanleyJJ,
pubmed-author:KrisM GMG,
pubmed-author:LeiberUU,
pubmed-author:LingC CCC,
pubmed-author:MychalczakBB,
pubmed-author:RabelGG,
pubmed-author:RosenzweigK EKE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
82-7
|
|
pubmed:dateRevised |
2011-1-11
|
|
pubmed:meshHeading |
pubmed-meshheading:11069224-Adult,
pubmed-meshheading:11069224-Aged,
pubmed-meshheading:11069224-Aged, 80 and over,
pubmed-meshheading:11069224-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11069224-Esophagus,
pubmed-meshheading:11069224-Female,
pubmed-meshheading:11069224-Humans,
pubmed-meshheading:11069224-Lung Neoplasms,
pubmed-meshheading:11069224-Male,
pubmed-meshheading:11069224-Middle Aged,
pubmed-meshheading:11069224-Neoplasm Staging,
pubmed-meshheading:11069224-Pneumonia,
pubmed-meshheading:11069224-Radiotherapy, Conformal,
pubmed-meshheading:11069224-Radiotherapy Dosage,
pubmed-meshheading:11069224-Survival Analysis,
pubmed-meshheading:11069224-Tomography Scanners, X-Ray Computed
|
|
pubmed:articleTitle |
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Clinical Trial, Phase I
|
